CEO finds new home at another drug co.: Bradley Sheares to lead Reliant Pharmaceuticals.

Bradley T. Sheares was named CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Reliant Pharmaceuticals Inc. in Liberty Corner, New Jersey, in January. This makes him one of the highest ranking and most visible African American African American Multiculture A person having origins in any of the black racial groups of Africa. See Race. senior executives in the pharmaceutical industry.

Sheares, 50, spent nearly 20 years working for Merch & Co. Inc., the drug manufacturer at the center of more than 11,000 multimillion-dollar lawsuits involving the drug Vioxx. He left the company in July in the wake of the lawsuits and an executive repositioning repositioning Laparoscopic surgery The changing of a Pt's position during a procedure to improve access or visualization of the operative field, which may be linked to complications, as it changes anatomic planes of operation. Cf Laparoscopic surgery. at Merck. Sheares is one of BE's 75 Most Powerful African Americans in Corporate America.

In his new position, Sheares will oversee the daily operations of the company, including the marketing of the firm's lead product, Omacor. The drug is a prescription Omega-3 fatty acid omega-3 fatty acid
n.
Any of various polyunsaturated fatty acids that are found primarily in fish, fish oils, vegetable oils, and leafy green vegetables, and that seem to reduce the risk of stroke and heart attack. that was recently approved by the Food and Drug Administration. The company employs more than 800 salespeople sales·peo·ple
pl.n.
Persons who are employed to sell merchandise in a store or in a designated territory. across the country.

"I'm thrilled to be joining Reliant at this promising time in the company's development," Sheares says. "With the successful release of Omacor, Reliant is well positioned for new growth."

COPYRIGHT 2007 Earl G. Graves Publishing Co., Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:	POWER PLAYER
Author:	Townes, Glenn
Publication:	Black Enterprise
Date:	Apr 1, 2007
Words:	174
Previous Article:	Madison Research sold.(B.E. 100s)
Next Article:	Mary Winston leaves scholastic.(POWER PLAYER)
Topics:	Pharmaceutical industry

Related Articles
WRONG PRESCRIPTION.(Bill Bradley's health reforms)
The Garibaldi Group targets NJ pharmaceutical market.(Brief Article)
A hard new material with a soft touch.(Brief Article)
ON THE MOVE.(News Briefs)(Brief Article)
Consultant to helm pharmaceutical firm. (People).(Rik Deitsch named president/chief executive of Nutra Pharma Corp.)(Brief Article)
BOTTOM LINE, IT'S ALL ABOUT KIDS BREATHING.(Viewpoint)
Premiers prescribe a federal government drug plan.(Health)
Merger strengthens Gamma's influence.(acquisitions of Gamma Medica)(divestments of Ideas ASA )
DODGERS ROCKY DAY ENDS WELL DEFEAT ROCKIES AFTER FLARE-UP DODGERS 8, COLORADO 3.(Sports)
Bradley Sheares resigns from Merck; analysts say Vioxx lawsuits may have led to management shake-up.(POWER PLAYER)(Bradley T. Sheares )(Brief article)